We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Validating an ELISpot for Early Detection of an Active Immune Response Against COVID-19 (EliSpot)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04418206
Recruitment Status : Completed
First Posted : June 5, 2020
Last Update Posted : October 25, 2022
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Nice

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Completed
Actual Primary Completion Date : February 10, 2022
Actual Study Completion Date : July 19, 2022